CTSB and neoplasm: Collectively, our findings demonstrate that FRRG-MMAE nanoparticles effectively inhibit the tumor growth, owing to the tumor-specific MMAE release and the high tumor accumulation due to the nanoparticle-derived EPR effect, as well as reduce MMAE-related toxicity by high cathepsin B-specificity, thereby allowing safe and effective chemotherapy.